Early ADME studies are an important part of drug discovery. The results of these studies are often used to identify the best drug candidates or shape the future development of pharmaceuticals. Conducting this testing at the very early phases can lead to early identification of any issues and reduce the risk of timeline-jeopardizing delays.
ADME stands for Absorption, Distribution, Metabolism, and Excretion, and refers to testing commonly conducted in pharmacokinetic and pharmacological studies. It describes the disposition of a pharmaceutical compound within an organism and has been typically used in the early phases of drug study to ascertain the safety and effectiveness of a substance before clinical trials.
Today, however, ADME and PK studies are used in conjunction to design a rational approach to drug research and preclinical ADME has become a mature discipline through the in vitro and in vivo methodologies. These methodologies involving ADME/PK studies are available at NoAb BioDiscoveries, and innovative research facility that delivers an extensive range of drug discovery services and resources designed to accelerate the drug development process. Through this range of specialized and proprietary services, NoAb BioDiscoveries assists you in shaping and optimizing drug research by providing comprehensive tools that facilitate success in a shorter amount of time. Through this approach, safe and effective drug candidates are produced in a timely manner, ensuring your success.
Clients of NoAb BioDiscoveries are able to analyze compounds for identification of the best candidates for further pre-clinical and clinical development as a result of in vivo and in vitro studies and gene expression assays. The group of experienced scientists at this acclaimed research facility is experienced in creating the most effective strategy and protocols to meet any drug discovery need. Studies are skillfully designed and conducted as standard procedures or customized to each client's needs and involve using fully conscious specimens that have been prepared for drug administration and sample collection in accordance with strict scientific and ethical guidelines. To examine study records and studies previously done by NoAb BioDiscoveries, browse through www.noabbiodiscoveries.com where detailed information is available on various case studies. A comprehensive list of the in-house services that include ADME/PK studies and gene expression is also available on the site.
The superior quality and highly effective ADME/PK profiling at NoAb BioDiscoveries helps to identifyand prioritize leads. In conjunction with the results of toxicity evaluations, hits from high throughput screening can be developed into leads which can then be optimized into promising drug candidates. Through ADME/PK profiling such as DTExâ"¢ micro array-based technology, investigators have been able to appreciate the effects of drug treatments in pre-clinical and clinical models and identify potential drug candidates. NoAb BioDiscoveries is committed to continue on the path of premier drug discovery so as to consistently deliver the best results to its clients!
Rely on NoAb BioDiscoveries to find you the most promising drug candidates using highly effective technologies such as ADME/PK profiling in the least amount of time and with the greatest accuracy. No one better appreciates that its success is entirely dependent on your success. For additional information on the extensive range of in vivo and in vitro services available from the facility, visit www.noabbiodiscoveries.com. If you need a drug design strategy customized to your specifications, you can contact the research facility with details at info@noabbiodiscoveries.com.
